Digital Therapeutics (DTx)

Digital Therapeutics (DTx) are a type of healthcare technology that utilizes software and mobile applications to deliver evidence-based therapeutic interventions to patients. These interventions aim to improve health outcomes and help manage various medical conditions, such as chronic diseases, mental health issues, and behavioral health challenges. DTx provide an alternative to traditional forms of therapy, such as drugs and in-person counseling, and can be delivered remotely, making them accessible to a larger patient population.

Digital Therapeutics Companies

We are working with in an alliance of providers, hardware manufactures, researchers, thought leaders and tech geeks to advance healthcare while activating consumer uptake!
#ARTLAB “A Rising Tide Lifts All Boats”

Remote Patient Monitoring

Connectivity is the key for patient care with real-time access for actionable data.

Hardware Manufactures

Hundereds of products are being developed to meet the needs of providers and consumers meeting the demand.

Providers

NextLevel Care is the future, and education, engagement and activation will be the key to success for all steakholders.

Consumars

Prompting the question and educating consumers to help move the industry forward, while supporting business growth for sustainability.

Digital Therapeutics Market

As the leader in patient education our provider referral platforms are engaging millions of high intent consumers actively leveraging various levels of technology in their patient journet. Our predective analytics and machiel learning nodes are hard at work providing meaningful data enabline change at scale.

Lorem ipsum dolor sit

As of 2021, the global digital therapeutics market size is estimated to be worth around $3 billion and is expected to grow rapidly in the coming years. Factors such as increasing demand for cost-effective and accessible healthcare solutions, growing acceptance of digital health technologies, and advancements in digital technologies are driving the growth of the digital therapeutics market. The market is expected to grow at a significant compound annual growth rate (CAGR) over the next decade, with projections indicating that the market could be worth over $20 billion by 2030.

Digital Therapeutics (DTx) reimbursement

Digital Therapeutics (DTx) reimbursement is a complex issue that is determined by various factors, including the type of DTx intervention, the patient population being treated, and the healthcare system in which the treatment is being delivered. Currently, DTx reimbursement varies depending on the country and healthcare system, with some countries offering reimbursement for specific DTx treatments, while others do not.

In the United States, DTx reimbursement is largely determined by the Current Procedural Terminology (CPT) codes used to bill for healthcare services. CPT codes are assigned to specific healthcare services and procedures, and DTx companies can apply for their interventions to be assigned a CPT code that will allow them to bill for their services. However, obtaining a CPT code for DTx interventions can be a time-consuming and costly process, and some DTx companies may not be able to secure reimbursement for their services.

International Classification of Diseases (ICD) codes are used by healthcare providers to classify diseases and medical conditions. DTx companies can apply for their interventions to be assigned an ICD code, which can help support reimbursement for their services. The ICD codes used for DTx interventions may also impact the type of patient population that can be treated and the types of medical conditions that can be addressed using DTx.

In summary, DTx reimbursement is a complex issue that is determined by a range of factors, including the healthcare system in which the treatment is being delivered, the type of DTx intervention, and the patient population being treated.

digital therapeutics programmers, Managers & Team Leads are in ULTRA HIGH DEMAND!

A Full Stack Programmer with digital therapeutics knowledge is a software developer who has a comprehensive understanding of the various technologies and processes involved in developing digital health solutions, with a specific focus on digital therapeutics. They should have expertise in several areas, including:

Front-end development: Knowledge of HTML, CSS, JavaScript, and other front-end technologies for building user-friendly and visually appealing digital health applications.

Back-end development: Knowledge of server-side technologies such as Python, Ruby, or PHP, and databases such as MySQL, MongoDB, or PostgreSQL for storing and retrieving data.

Mobile development: Knowledge of iOS or Android development and the ability to build native or cross-platform mobile applications.

Cloud computing: Knowledge of cloud computing technologies, such as Amazon Web Services (AWS) or Google Cloud Platform (GCP), for scaling and deploying digital health solutions.

Healthcare domain knowledge: Understanding of the healthcare industry and digital health regulations, as well as an understanding of the medical conditions and patient populations that digital therapeutics aim to treat.

In addition to these technical skills, a Full Stack Programmer with digital therapeutics knowledge should also have strong problem-solving and critical thinking skills, as well as the ability to work collaboratively in a team environment. They should be able to design and develop user-centered digital health solutions that meet the specific needs of patients, healthcare providers, and other stakeholders.

Digital Therapeutics (DTx)

Digital Therapeutics (DTx)